nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—HRH3—epilepsy syndrome	0.287	0.696	CbGaD
Donepezil—HTR2A—epilepsy syndrome	0.0654	0.159	CbGaD
Donepezil—CYP2D6—epilepsy syndrome	0.0598	0.145	CbGaD
Donepezil—CYP2C9—Trimethadione—epilepsy syndrome	0.0208	0.074	CbGbCtD
Donepezil—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0196	0.0696	CbGbCtD
Donepezil—CYP2C9—Carbamazepine—epilepsy syndrome	0.0141	0.05	CbGbCtD
Donepezil—CYP2C9—Primidone—epilepsy syndrome	0.0131	0.0467	CbGbCtD
Donepezil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.013	0.0463	CbGbCtD
Donepezil—CYP2C9—Phenytoin—epilepsy syndrome	0.0126	0.0449	CbGbCtD
Donepezil—CYP3A4—Felbamate—epilepsy syndrome	0.0121	0.043	CbGbCtD
Donepezil—CYP3A4—Trimethadione—epilepsy syndrome	0.0121	0.043	CbGbCtD
Donepezil—CYP2C9—Propofol—epilepsy syndrome	0.0118	0.0418	CbGbCtD
Donepezil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0114	0.0405	CbGbCtD
Donepezil—CYP2C9—Phenobarbital—epilepsy syndrome	0.0112	0.04	CbGbCtD
Donepezil—CYP2D6—Propofol—epilepsy syndrome	0.0107	0.0382	CbGbCtD
Donepezil—CYP2C9—Diazepam—epilepsy syndrome	0.0106	0.0379	CbGbCtD
Donepezil—CYP3A4—Clonazepam—epilepsy syndrome	0.0103	0.0366	CbGbCtD
Donepezil—CYP3A4—Clobazam—epilepsy syndrome	0.00986	0.0351	CbGbCtD
Donepezil—CYP2C9—Valproic Acid—epilepsy syndrome	0.00839	0.0299	CbGbCtD
Donepezil—CYP3A4—Rufinamide—epilepsy syndrome	0.00838	0.0298	CbGbCtD
Donepezil—CYP3A4—Carbamazepine—epilepsy syndrome	0.00817	0.0291	CbGbCtD
Donepezil—CYP3A4—Primidone—epilepsy syndrome	0.00763	0.0271	CbGbCtD
Donepezil—CYP3A4—Phenytoin—epilepsy syndrome	0.00733	0.0261	CbGbCtD
Donepezil—CYP3A4—Propofol—epilepsy syndrome	0.00683	0.0243	CbGbCtD
Donepezil—CYP3A4—Acetazolamide—epilepsy syndrome	0.00653	0.0232	CbGbCtD
Donepezil—CYP3A4—Phenobarbital—epilepsy syndrome	0.00653	0.0232	CbGbCtD
Donepezil—CYP3A4—Midazolam—epilepsy syndrome	0.00644	0.0229	CbGbCtD
Donepezil—CYP3A4—Diazepam—epilepsy syndrome	0.00619	0.022	CbGbCtD
Donepezil—CYP3A4—Zonisamide—epilepsy syndrome	0.00604	0.0215	CbGbCtD
Donepezil—HTR2A—phrenic nerve—epilepsy syndrome	0.00562	0.142	CbGeAlD
Donepezil—CYP3A4—Valproic Acid—epilepsy syndrome	0.00488	0.0174	CbGbCtD
Donepezil—CYP3A4—Topiramate—epilepsy syndrome	0.0044	0.0157	CbGbCtD
Donepezil—HRH3—hindbrain—epilepsy syndrome	0.00291	0.0736	CbGeAlD
Donepezil—HTR2A—locus ceruleus—epilepsy syndrome	0.00251	0.0636	CbGeAlD
Donepezil—HTR2A—cerebellar cortex—epilepsy syndrome	0.00205	0.0518	CbGeAlD
Donepezil—HTR2A—vagus nerve—epilepsy syndrome	0.00192	0.0487	CbGeAlD
Donepezil—HRH3—brainstem—epilepsy syndrome	0.00167	0.0422	CbGeAlD
Donepezil—HRH3—forebrain—epilepsy syndrome	0.00161	0.0407	CbGeAlD
Donepezil—HRH3—telencephalon—epilepsy syndrome	0.00148	0.0374	CbGeAlD
Donepezil—HTR2A—pons—epilepsy syndrome	0.00145	0.0366	CbGeAlD
Donepezil—HTR2A—autonomic nervous system—epilepsy syndrome	0.00133	0.0338	CbGeAlD
Donepezil—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00119	0.0301	CbGeAlD
Donepezil—HRH3—head—epilepsy syndrome	0.00092	0.0233	CbGeAlD
Donepezil—HRH3—nervous system—epilepsy syndrome	0.000873	0.0221	CbGeAlD
Donepezil—HRH3—central nervous system—epilepsy syndrome	0.00084	0.0213	CbGeAlD
Donepezil—HRH3—cerebellum—epilepsy syndrome	0.000821	0.0208	CbGeAlD
Donepezil—ACHE—telencephalon—epilepsy syndrome	0.0008	0.0202	CbGeAlD
Donepezil—HTR2A—ganglion—epilepsy syndrome	0.000741	0.0188	CbGeAlD
Donepezil—Tetrabenazine—CYP2D6—epilepsy syndrome	0.000719	0.346	CrCbGaD
Donepezil—HRH3—brain—epilepsy syndrome	0.000667	0.0169	CbGeAlD
Donepezil—ACHE—medulla oblongata—epilepsy syndrome	0.000628	0.0159	CbGeAlD
Donepezil—ACHE—midbrain—epilepsy syndrome	0.000574	0.0145	CbGeAlD
Donepezil—HTR2A—hindbrain—epilepsy syndrome	0.000562	0.0142	CbGeAlD
Donepezil—ACHE—spinal cord—epilepsy syndrome	0.00056	0.0142	CbGeAlD
Donepezil—SIGMAR1—telencephalon—epilepsy syndrome	0.000537	0.0136	CbGeAlD
Donepezil—Doxazosin—ADRA2A—epilepsy syndrome	0.000514	0.247	CrCbGaD
Donepezil—CYP2D6—hindbrain—epilepsy syndrome	0.000512	0.013	CbGeAlD
Donepezil—ACHE—cerebellum—epilepsy syndrome	0.000444	0.0112	CbGeAlD
Donepezil—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000422	0.0107	CbGeAlD
Donepezil—SIGMAR1—midbrain—epilepsy syndrome	0.000385	0.00975	CbGeAlD
Donepezil—SIGMAR1—spinal cord—epilepsy syndrome	0.000376	0.00952	CbGeAlD
Donepezil—Doxazosin—CYP2C19—epilepsy syndrome	0.000372	0.179	CrCbGaD
Donepezil—ACHE—brain—epilepsy syndrome	0.000361	0.00914	CbGeAlD
Donepezil—HTR2A—brainstem—epilepsy syndrome	0.000322	0.00815	CbGeAlD
Donepezil—HTR2A—forebrain—epilepsy syndrome	0.000311	0.00787	CbGeAlD
Donepezil—SIGMAR1—cerebellum—epilepsy syndrome	0.000298	0.00755	CbGeAlD
Donepezil—CYP2D6—brainstem—epilepsy syndrome	0.000293	0.00743	CbGeAlD
Donepezil—HTR2A—telencephalon—epilepsy syndrome	0.000286	0.00724	CbGeAlD
Donepezil—CYP2D6—forebrain—epilepsy syndrome	0.000283	0.00717	CbGeAlD
Donepezil—Doxazosin—CYP2D6—epilepsy syndrome	0.000276	0.133	CrCbGaD
Donepezil—CYP2D6—telencephalon—epilepsy syndrome	0.00026	0.00659	CbGeAlD
Donepezil—SIGMAR1—brain—epilepsy syndrome	0.000242	0.00613	CbGeAlD
Donepezil—HTR2A—medulla oblongata—epilepsy syndrome	0.000225	0.00569	CbGeAlD
Donepezil—HTR2A—midbrain—epilepsy syndrome	0.000205	0.0052	CbGeAlD
Donepezil—HTR2A—spinal cord—epilepsy syndrome	0.0002	0.00507	CbGeAlD
Donepezil—Doxazosin—ABCB1—epilepsy syndrome	0.000197	0.0947	CrCbGaD
Donepezil—HTR2A—head—epilepsy syndrome	0.000178	0.00451	CbGeAlD
Donepezil—HTR2A—nervous system—epilepsy syndrome	0.000169	0.00427	CbGeAlD
Donepezil—HTR2A—central nervous system—epilepsy syndrome	0.000162	0.00411	CbGeAlD
Donepezil—CYP2D6—head—epilepsy syndrome	0.000162	0.0041	CbGeAlD
Donepezil—HTR2A—cerebellum—epilepsy syndrome	0.000159	0.00402	CbGeAlD
Donepezil—CYP3A4—nervous system—epilepsy syndrome	0.000156	0.00395	CbGeAlD
Donepezil—CYP2D6—nervous system—epilepsy syndrome	0.000154	0.00389	CbGeAlD
Donepezil—CYP3A4—central nervous system—epilepsy syndrome	0.00015	0.00381	CbGeAlD
Donepezil—CYP2D6—central nervous system—epilepsy syndrome	0.000148	0.00375	CbGeAlD
Donepezil—CYP2D6—cerebellum—epilepsy syndrome	0.000145	0.00366	CbGeAlD
Donepezil—HTR2A—brain—epilepsy syndrome	0.000129	0.00327	CbGeAlD
Donepezil—CYP2D6—brain—epilepsy syndrome	0.000118	0.00297	CbGeAlD
Donepezil—Pruritus—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000115	CcSEcCtD
Donepezil—Convulsion—Pregabalin—epilepsy syndrome	2.31e-05	0.000115	CcSEcCtD
Donepezil—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.31e-05	0.000115	CcSEcCtD
Donepezil—Vision blurred—Gabapentin—epilepsy syndrome	2.3e-05	0.000115	CcSEcCtD
Donepezil—Headache—Vigabatrin—epilepsy syndrome	2.3e-05	0.000115	CcSEcCtD
Donepezil—Hypertension—Pregabalin—epilepsy syndrome	2.3e-05	0.000115	CcSEcCtD
Donepezil—Vomiting—Diazepam—epilepsy syndrome	2.3e-05	0.000115	CcSEcCtD
Donepezil—Anorexia—Valproic Acid—epilepsy syndrome	2.29e-05	0.000114	CcSEcCtD
Donepezil—Tremor—Gabapentin—epilepsy syndrome	2.29e-05	0.000114	CcSEcCtD
Donepezil—Rash—Diazepam—epilepsy syndrome	2.28e-05	0.000114	CcSEcCtD
Donepezil—Dermatitis—Diazepam—epilepsy syndrome	2.28e-05	0.000113	CcSEcCtD
Donepezil—Visual impairment—Topiramate—epilepsy syndrome	2.28e-05	0.000113	CcSEcCtD
Donepezil—Arthralgia—Pregabalin—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Myalgia—Pregabalin—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Chest pain—Pregabalin—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Dizziness—Zonisamide—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Headache—Diazepam—epilepsy syndrome	2.27e-05	0.000113	CcSEcCtD
Donepezil—Anxiety—Pregabalin—epilepsy syndrome	2.26e-05	0.000113	CcSEcCtD
Donepezil—Diarrhoea—Clonazepam—epilepsy syndrome	2.26e-05	0.000113	CcSEcCtD
Donepezil—Anaemia—Gabapentin—epilepsy syndrome	2.26e-05	0.000112	CcSEcCtD
Donepezil—Hypotension—Valproic Acid—epilepsy syndrome	2.25e-05	0.000112	CcSEcCtD
Donepezil—Asthenia—Carbamazepine—epilepsy syndrome	2.25e-05	0.000112	CcSEcCtD
Donepezil—Agitation—Gabapentin—epilepsy syndrome	2.25e-05	0.000112	CcSEcCtD
Donepezil—Diarrhoea—Phenytoin—epilepsy syndrome	2.25e-05	0.000112	CcSEcCtD
Donepezil—Discomfort—Pregabalin—epilepsy syndrome	2.24e-05	0.000112	CcSEcCtD
Donepezil—Nausea—Fosphenytoin—epilepsy syndrome	2.24e-05	0.000112	CcSEcCtD
Donepezil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.23e-05	0.000111	CcSEcCtD
Donepezil—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.23e-05	0.000111	CcSEcCtD
Donepezil—Vomiting—Felbamate—epilepsy syndrome	2.23e-05	0.000111	CcSEcCtD
Donepezil—Dry mouth—Pregabalin—epilepsy syndrome	2.22e-05	0.00011	CcSEcCtD
Donepezil—Pruritus—Carbamazepine—epilepsy syndrome	2.22e-05	0.00011	CcSEcCtD
Donepezil—Rash—Felbamate—epilepsy syndrome	2.21e-05	0.00011	CcSEcCtD
Donepezil—Dermatitis—Felbamate—epilepsy syndrome	2.21e-05	0.00011	CcSEcCtD
Donepezil—Malaise—Gabapentin—epilepsy syndrome	2.2e-05	0.00011	CcSEcCtD
Donepezil—Tinnitus—Topiramate—epilepsy syndrome	2.2e-05	0.00011	CcSEcCtD
Donepezil—Vertigo—Gabapentin—epilepsy syndrome	2.2e-05	0.000109	CcSEcCtD
Donepezil—Headache—Felbamate—epilepsy syndrome	2.19e-05	0.000109	CcSEcCtD
Donepezil—Confusional state—Pregabalin—epilepsy syndrome	2.19e-05	0.000109	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.19e-05	0.000109	CcSEcCtD
Donepezil—Syncope—Gabapentin—epilepsy syndrome	2.19e-05	0.000109	CcSEcCtD
Donepezil—Dizziness—Clonazepam—epilepsy syndrome	2.19e-05	0.000109	CcSEcCtD
Donepezil—Nausea—Vigabatrin—epilepsy syndrome	2.18e-05	0.000109	CcSEcCtD
Donepezil—Vomiting—Zonisamide—epilepsy syndrome	2.18e-05	0.000109	CcSEcCtD
Donepezil—Insomnia—Valproic Acid—epilepsy syndrome	2.18e-05	0.000108	CcSEcCtD
Donepezil—Oedema—Pregabalin—epilepsy syndrome	2.18e-05	0.000108	CcSEcCtD
Donepezil—Asthenia—Lamotrigine—epilepsy syndrome	2.17e-05	0.000108	CcSEcCtD
Donepezil—Dizziness—Phenytoin—epilepsy syndrome	2.17e-05	0.000108	CcSEcCtD
Donepezil—Rash—Zonisamide—epilepsy syndrome	2.16e-05	0.000108	CcSEcCtD
Donepezil—Infection—Pregabalin—epilepsy syndrome	2.16e-05	0.000108	CcSEcCtD
Donepezil—Paraesthesia—Valproic Acid—epilepsy syndrome	2.16e-05	0.000108	CcSEcCtD
Donepezil—Dermatitis—Zonisamide—epilepsy syndrome	2.16e-05	0.000108	CcSEcCtD
Donepezil—Dizziness—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000107	CcSEcCtD
Donepezil—Nausea—Diazepam—epilepsy syndrome	2.15e-05	0.000107	CcSEcCtD
Donepezil—Loss of consciousness—Gabapentin—epilepsy syndrome	2.15e-05	0.000107	CcSEcCtD
Donepezil—Headache—Zonisamide—epilepsy syndrome	2.15e-05	0.000107	CcSEcCtD
Donepezil—Dyspnoea—Valproic Acid—epilepsy syndrome	2.15e-05	0.000107	CcSEcCtD
Donepezil—Diarrhoea—Carbamazepine—epilepsy syndrome	2.14e-05	0.000107	CcSEcCtD
Donepezil—Pruritus—Lamotrigine—epilepsy syndrome	2.14e-05	0.000107	CcSEcCtD
Donepezil—Shock—Pregabalin—epilepsy syndrome	2.14e-05	0.000107	CcSEcCtD
Donepezil—Somnolence—Valproic Acid—epilepsy syndrome	2.14e-05	0.000106	CcSEcCtD
Donepezil—Nervous system disorder—Pregabalin—epilepsy syndrome	2.13e-05	0.000106	CcSEcCtD
Donepezil—Cough—Gabapentin—epilepsy syndrome	2.13e-05	0.000106	CcSEcCtD
Donepezil—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.13e-05	0.000106	CcSEcCtD
Donepezil—Chills—Topiramate—epilepsy syndrome	2.12e-05	0.000106	CcSEcCtD
Donepezil—Dyspepsia—Valproic Acid—epilepsy syndrome	2.12e-05	0.000105	CcSEcCtD
Donepezil—Convulsion—Gabapentin—epilepsy syndrome	2.12e-05	0.000105	CcSEcCtD
Donepezil—Hypertension—Gabapentin—epilepsy syndrome	2.11e-05	0.000105	CcSEcCtD
Donepezil—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.1e-05	0.000105	CcSEcCtD
Donepezil—Vomiting—Clonazepam—epilepsy syndrome	2.1e-05	0.000105	CcSEcCtD
Donepezil—Decreased appetite—Valproic Acid—epilepsy syndrome	2.09e-05	0.000104	CcSEcCtD
Donepezil—Alopecia—Topiramate—epilepsy syndrome	2.09e-05	0.000104	CcSEcCtD
Donepezil—Vomiting—Phenytoin—epilepsy syndrome	2.09e-05	0.000104	CcSEcCtD
Donepezil—Rash—Clonazepam—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Dermatitis—Clonazepam—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Myalgia—Gabapentin—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Chest pain—Gabapentin—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Arthralgia—Gabapentin—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Nausea—Felbamate—epilepsy syndrome	2.08e-05	0.000104	CcSEcCtD
Donepezil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.08e-05	0.000103	CcSEcCtD
Donepezil—Vomiting—Oxcarbazepine—epilepsy syndrome	2.08e-05	0.000103	CcSEcCtD
Donepezil—Fatigue—Valproic Acid—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Anxiety—Gabapentin—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Anorexia—Pregabalin—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Dizziness—Carbamazepine—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Diarrhoea—Lamotrigine—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Headache—Clonazepam—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Rash—Phenytoin—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Mental disorder—Topiramate—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Dermatitis—Phenytoin—epilepsy syndrome	2.07e-05	0.000103	CcSEcCtD
Donepezil—Rash—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Constipation—Valproic Acid—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Pain—Valproic Acid—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Headache—Phenytoin—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Erythema—Topiramate—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Malnutrition—Topiramate—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Discomfort—Gabapentin—epilepsy syndrome	2.06e-05	0.000102	CcSEcCtD
Donepezil—Headache—Oxcarbazepine—epilepsy syndrome	2.05e-05	0.000102	CcSEcCtD
Donepezil—Nausea—Zonisamide—epilepsy syndrome	2.04e-05	0.000101	CcSEcCtD
Donepezil—Dry mouth—Gabapentin—epilepsy syndrome	2.03e-05	0.000101	CcSEcCtD
Donepezil—Hypotension—Pregabalin—epilepsy syndrome	2.03e-05	0.000101	CcSEcCtD
Donepezil—Flatulence—Topiramate—epilepsy syndrome	2.03e-05	0.000101	CcSEcCtD
Donepezil—Tension—Topiramate—epilepsy syndrome	2.02e-05	0.0001	CcSEcCtD
Donepezil—Dysgeusia—Topiramate—epilepsy syndrome	2.01e-05	0.0001	CcSEcCtD
Donepezil—Confusional state—Gabapentin—epilepsy syndrome	2.01e-05	0.0001	CcSEcCtD
Donepezil—Dizziness—Lamotrigine—epilepsy syndrome	2e-05	9.97e-05	CcSEcCtD
Donepezil—Nervousness—Topiramate—epilepsy syndrome	2e-05	9.94e-05	CcSEcCtD
Donepezil—Oedema—Gabapentin—epilepsy syndrome	1.99e-05	9.93e-05	CcSEcCtD
Donepezil—Vomiting—Carbamazepine—epilepsy syndrome	1.99e-05	9.92e-05	CcSEcCtD
Donepezil—Back pain—Topiramate—epilepsy syndrome	1.99e-05	9.9e-05	CcSEcCtD
Donepezil—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.98e-05	9.87e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.98e-05	9.87e-05	CcSEcCtD
Donepezil—Infection—Gabapentin—epilepsy syndrome	1.98e-05	9.87e-05	CcSEcCtD
Donepezil—Muscle spasms—Topiramate—epilepsy syndrome	1.98e-05	9.84e-05	CcSEcCtD
Donepezil—Rash—Carbamazepine—epilepsy syndrome	1.98e-05	9.83e-05	CcSEcCtD
Donepezil—Dermatitis—Carbamazepine—epilepsy syndrome	1.97e-05	9.83e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.97e-05	9.8e-05	CcSEcCtD
Donepezil—Insomnia—Pregabalin—epilepsy syndrome	1.97e-05	9.79e-05	CcSEcCtD
Donepezil—Nausea—Clonazepam—epilepsy syndrome	1.96e-05	9.77e-05	CcSEcCtD
Donepezil—Headache—Carbamazepine—epilepsy syndrome	1.96e-05	9.77e-05	CcSEcCtD
Donepezil—Shock—Gabapentin—epilepsy syndrome	1.96e-05	9.77e-05	CcSEcCtD
Donepezil—Nervous system disorder—Gabapentin—epilepsy syndrome	1.96e-05	9.74e-05	CcSEcCtD
Donepezil—Paraesthesia—Pregabalin—epilepsy syndrome	1.95e-05	9.72e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.95e-05	9.72e-05	CcSEcCtD
Donepezil—Nausea—Phenytoin—epilepsy syndrome	1.95e-05	9.71e-05	CcSEcCtD
Donepezil—Dyspnoea—Pregabalin—epilepsy syndrome	1.94e-05	9.65e-05	CcSEcCtD
Donepezil—Nausea—Oxcarbazepine—epilepsy syndrome	1.94e-05	9.65e-05	CcSEcCtD
Donepezil—Vision blurred—Topiramate—epilepsy syndrome	1.94e-05	9.65e-05	CcSEcCtD
Donepezil—Somnolence—Pregabalin—epilepsy syndrome	1.93e-05	9.63e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.93e-05	9.6e-05	CcSEcCtD
Donepezil—Tremor—Topiramate—epilepsy syndrome	1.93e-05	9.59e-05	CcSEcCtD
Donepezil—Vomiting—Lamotrigine—epilepsy syndrome	1.93e-05	9.58e-05	CcSEcCtD
Donepezil—Urticaria—Valproic Acid—epilepsy syndrome	1.91e-05	9.52e-05	CcSEcCtD
Donepezil—Rash—Lamotrigine—epilepsy syndrome	1.91e-05	9.5e-05	CcSEcCtD
Donepezil—Ill-defined disorder—Topiramate—epilepsy syndrome	1.91e-05	9.5e-05	CcSEcCtD
Donepezil—Dermatitis—Lamotrigine—epilepsy syndrome	1.91e-05	9.5e-05	CcSEcCtD
Donepezil—Abdominal pain—Valproic Acid—epilepsy syndrome	1.9e-05	9.47e-05	CcSEcCtD
Donepezil—Body temperature increased—Valproic Acid—epilepsy syndrome	1.9e-05	9.47e-05	CcSEcCtD
Donepezil—Anorexia—Gabapentin—epilepsy syndrome	1.9e-05	9.47e-05	CcSEcCtD
Donepezil—Anaemia—Topiramate—epilepsy syndrome	1.9e-05	9.46e-05	CcSEcCtD
Donepezil—Headache—Lamotrigine—epilepsy syndrome	1.9e-05	9.44e-05	CcSEcCtD
Donepezil—Decreased appetite—Pregabalin—epilepsy syndrome	1.89e-05	9.41e-05	CcSEcCtD
Donepezil—Agitation—Topiramate—epilepsy syndrome	1.89e-05	9.41e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.88e-05	9.35e-05	CcSEcCtD
Donepezil—Fatigue—Pregabalin—epilepsy syndrome	1.88e-05	9.34e-05	CcSEcCtD
Donepezil—Hypotension—Gabapentin—epilepsy syndrome	1.86e-05	9.28e-05	CcSEcCtD
Donepezil—Nausea—Carbamazepine—epilepsy syndrome	1.86e-05	9.26e-05	CcSEcCtD
Donepezil—Constipation—Pregabalin—epilepsy syndrome	1.86e-05	9.26e-05	CcSEcCtD
Donepezil—Pain—Pregabalin—epilepsy syndrome	1.86e-05	9.26e-05	CcSEcCtD
Donepezil—Malaise—Topiramate—epilepsy syndrome	1.85e-05	9.23e-05	CcSEcCtD
Donepezil—Vertigo—Topiramate—epilepsy syndrome	1.85e-05	9.2e-05	CcSEcCtD
Donepezil—Syncope—Topiramate—epilepsy syndrome	1.84e-05	9.18e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.82e-05	9.05e-05	CcSEcCtD
Donepezil—Loss of consciousness—Topiramate—epilepsy syndrome	1.81e-05	9e-05	CcSEcCtD
Donepezil—Insomnia—Gabapentin—epilepsy syndrome	1.8e-05	8.98e-05	CcSEcCtD
Donepezil—Nausea—Lamotrigine—epilepsy syndrome	1.8e-05	8.95e-05	CcSEcCtD
Donepezil—Cough—Topiramate—epilepsy syndrome	1.79e-05	8.93e-05	CcSEcCtD
Donepezil—Feeling abnormal—Pregabalin—epilepsy syndrome	1.79e-05	8.92e-05	CcSEcCtD
Donepezil—Paraesthesia—Gabapentin—epilepsy syndrome	1.79e-05	8.92e-05	CcSEcCtD
Donepezil—Convulsion—Topiramate—epilepsy syndrome	1.78e-05	8.87e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.78e-05	8.86e-05	CcSEcCtD
Donepezil—Dyspnoea—Gabapentin—epilepsy syndrome	1.78e-05	8.85e-05	CcSEcCtD
Donepezil—Hypertension—Topiramate—epilepsy syndrome	1.78e-05	8.84e-05	CcSEcCtD
Donepezil—Somnolence—Gabapentin—epilepsy syndrome	1.77e-05	8.83e-05	CcSEcCtD
Donepezil—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.77e-05	8.83e-05	CcSEcCtD
Donepezil—Dyspepsia—Gabapentin—epilepsy syndrome	1.76e-05	8.74e-05	CcSEcCtD
Donepezil—Arthralgia—Topiramate—epilepsy syndrome	1.75e-05	8.71e-05	CcSEcCtD
Donepezil—Myalgia—Topiramate—epilepsy syndrome	1.75e-05	8.71e-05	CcSEcCtD
Donepezil—Chest pain—Topiramate—epilepsy syndrome	1.75e-05	8.71e-05	CcSEcCtD
Donepezil—Anxiety—Topiramate—epilepsy syndrome	1.74e-05	8.68e-05	CcSEcCtD
Donepezil—Decreased appetite—Gabapentin—epilepsy syndrome	1.73e-05	8.63e-05	CcSEcCtD
Donepezil—Discomfort—Topiramate—epilepsy syndrome	1.73e-05	8.61e-05	CcSEcCtD
Donepezil—Urticaria—Pregabalin—epilepsy syndrome	1.73e-05	8.6e-05	CcSEcCtD
Donepezil—Asthenia—Valproic Acid—epilepsy syndrome	1.73e-05	8.59e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.72e-05	8.57e-05	CcSEcCtD
Donepezil—Fatigue—Gabapentin—epilepsy syndrome	1.72e-05	8.56e-05	CcSEcCtD
Donepezil—Abdominal pain—Pregabalin—epilepsy syndrome	1.72e-05	8.56e-05	CcSEcCtD
Donepezil—Body temperature increased—Pregabalin—epilepsy syndrome	1.72e-05	8.56e-05	CcSEcCtD
Donepezil—Dry mouth—Topiramate—epilepsy syndrome	1.71e-05	8.52e-05	CcSEcCtD
Donepezil—Pain—Gabapentin—epilepsy syndrome	1.71e-05	8.49e-05	CcSEcCtD
Donepezil—Constipation—Gabapentin—epilepsy syndrome	1.71e-05	8.49e-05	CcSEcCtD
Donepezil—Pruritus—Valproic Acid—epilepsy syndrome	1.7e-05	8.47e-05	CcSEcCtD
Donepezil—Confusional state—Topiramate—epilepsy syndrome	1.69e-05	8.42e-05	CcSEcCtD
Donepezil—Oedema—Topiramate—epilepsy syndrome	1.68e-05	8.35e-05	CcSEcCtD
Donepezil—Infection—Topiramate—epilepsy syndrome	1.67e-05	8.3e-05	CcSEcCtD
Donepezil—Shock—Topiramate—epilepsy syndrome	1.65e-05	8.22e-05	CcSEcCtD
Donepezil—Diarrhoea—Valproic Acid—epilepsy syndrome	1.65e-05	8.2e-05	CcSEcCtD
Donepezil—Nervous system disorder—Topiramate—epilepsy syndrome	1.65e-05	8.19e-05	CcSEcCtD
Donepezil—Feeling abnormal—Gabapentin—epilepsy syndrome	1.64e-05	8.18e-05	CcSEcCtD
Donepezil—Thrombocytopenia—Topiramate—epilepsy syndrome	1.64e-05	8.18e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.63e-05	8.12e-05	CcSEcCtD
Donepezil—Hyperhidrosis—Topiramate—epilepsy syndrome	1.62e-05	8.08e-05	CcSEcCtD
Donepezil—Hypersensitivity—Pregabalin—epilepsy syndrome	1.6e-05	7.98e-05	CcSEcCtD
Donepezil—Anorexia—Topiramate—epilepsy syndrome	1.6e-05	7.96e-05	CcSEcCtD
Donepezil—Dizziness—Valproic Acid—epilepsy syndrome	1.59e-05	7.92e-05	CcSEcCtD
Donepezil—Urticaria—Gabapentin—epilepsy syndrome	1.58e-05	7.89e-05	CcSEcCtD
Donepezil—Abdominal pain—Gabapentin—epilepsy syndrome	1.58e-05	7.85e-05	CcSEcCtD
Donepezil—Body temperature increased—Gabapentin—epilepsy syndrome	1.58e-05	7.85e-05	CcSEcCtD
Donepezil—Hypotension—Topiramate—epilepsy syndrome	1.57e-05	7.81e-05	CcSEcCtD
Donepezil—Asthenia—Pregabalin—epilepsy syndrome	1.56e-05	7.77e-05	CcSEcCtD
Donepezil—Pruritus—Pregabalin—epilepsy syndrome	1.54e-05	7.66e-05	CcSEcCtD
Donepezil—Vomiting—Valproic Acid—epilepsy syndrome	1.53e-05	7.62e-05	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.53e-05	7.61e-05	CcSEcCtD
Donepezil—Insomnia—Topiramate—epilepsy syndrome	1.52e-05	7.56e-05	CcSEcCtD
Donepezil—Rash—Valproic Acid—epilepsy syndrome	1.52e-05	7.55e-05	CcSEcCtD
Donepezil—Dermatitis—Valproic Acid—epilepsy syndrome	1.52e-05	7.55e-05	CcSEcCtD
Donepezil—Headache—Valproic Acid—epilepsy syndrome	1.51e-05	7.5e-05	CcSEcCtD
Donepezil—Paraesthesia—Topiramate—epilepsy syndrome	1.51e-05	7.5e-05	CcSEcCtD
Donepezil—Dyspnoea—Topiramate—epilepsy syndrome	1.5e-05	7.45e-05	CcSEcCtD
Donepezil—Somnolence—Topiramate—epilepsy syndrome	1.49e-05	7.43e-05	CcSEcCtD
Donepezil—Diarrhoea—Pregabalin—epilepsy syndrome	1.49e-05	7.41e-05	CcSEcCtD
Donepezil—Dyspepsia—Topiramate—epilepsy syndrome	1.48e-05	7.35e-05	CcSEcCtD
Donepezil—Hypersensitivity—Gabapentin—epilepsy syndrome	1.47e-05	7.32e-05	CcSEcCtD
Donepezil—Decreased appetite—Topiramate—epilepsy syndrome	1.46e-05	7.26e-05	CcSEcCtD
Donepezil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.45e-05	7.21e-05	CcSEcCtD
Donepezil—Fatigue—Topiramate—epilepsy syndrome	1.45e-05	7.2e-05	CcSEcCtD
Donepezil—Dizziness—Pregabalin—epilepsy syndrome	1.44e-05	7.16e-05	CcSEcCtD
Donepezil—Pain—Topiramate—epilepsy syndrome	1.44e-05	7.14e-05	CcSEcCtD
Donepezil—Constipation—Topiramate—epilepsy syndrome	1.44e-05	7.14e-05	CcSEcCtD
Donepezil—Asthenia—Gabapentin—epilepsy syndrome	1.43e-05	7.12e-05	CcSEcCtD
Donepezil—Nausea—Valproic Acid—epilepsy syndrome	1.43e-05	7.12e-05	CcSEcCtD
Donepezil—Pruritus—Gabapentin—epilepsy syndrome	1.41e-05	7.03e-05	CcSEcCtD
Donepezil—Vomiting—Pregabalin—epilepsy syndrome	1.38e-05	6.89e-05	CcSEcCtD
Donepezil—Feeling abnormal—Topiramate—epilepsy syndrome	1.38e-05	6.88e-05	CcSEcCtD
Donepezil—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.37e-05	6.83e-05	CcSEcCtD
Donepezil—Rash—Pregabalin—epilepsy syndrome	1.37e-05	6.83e-05	CcSEcCtD
Donepezil—Dermatitis—Pregabalin—epilepsy syndrome	1.37e-05	6.82e-05	CcSEcCtD
Donepezil—Diarrhoea—Gabapentin—epilepsy syndrome	1.36e-05	6.79e-05	CcSEcCtD
Donepezil—Headache—Pregabalin—epilepsy syndrome	1.36e-05	6.78e-05	CcSEcCtD
Donepezil—Urticaria—Topiramate—epilepsy syndrome	1.33e-05	6.64e-05	CcSEcCtD
Donepezil—Body temperature increased—Topiramate—epilepsy syndrome	1.33e-05	6.6e-05	CcSEcCtD
Donepezil—Abdominal pain—Topiramate—epilepsy syndrome	1.33e-05	6.6e-05	CcSEcCtD
Donepezil—Dizziness—Gabapentin—epilepsy syndrome	1.32e-05	6.57e-05	CcSEcCtD
Donepezil—Nausea—Pregabalin—epilepsy syndrome	1.29e-05	6.43e-05	CcSEcCtD
Donepezil—Vomiting—Gabapentin—epilepsy syndrome	1.27e-05	6.31e-05	CcSEcCtD
Donepezil—Rash—Gabapentin—epilepsy syndrome	1.26e-05	6.26e-05	CcSEcCtD
Donepezil—Dermatitis—Gabapentin—epilepsy syndrome	1.26e-05	6.26e-05	CcSEcCtD
Donepezil—Headache—Gabapentin—epilepsy syndrome	1.25e-05	6.22e-05	CcSEcCtD
Donepezil—Hypersensitivity—Topiramate—epilepsy syndrome	1.24e-05	6.16e-05	CcSEcCtD
Donepezil—Asthenia—Topiramate—epilepsy syndrome	1.2e-05	5.99e-05	CcSEcCtD
Donepezil—Pruritus—Topiramate—epilepsy syndrome	1.19e-05	5.91e-05	CcSEcCtD
Donepezil—Nausea—Gabapentin—epilepsy syndrome	1.18e-05	5.9e-05	CcSEcCtD
Donepezil—Diarrhoea—Topiramate—epilepsy syndrome	1.15e-05	5.72e-05	CcSEcCtD
Donepezil—Dizziness—Topiramate—epilepsy syndrome	1.11e-05	5.52e-05	CcSEcCtD
Donepezil—Vomiting—Topiramate—epilepsy syndrome	1.07e-05	5.31e-05	CcSEcCtD
Donepezil—Rash—Topiramate—epilepsy syndrome	1.06e-05	5.27e-05	CcSEcCtD
Donepezil—Dermatitis—Topiramate—epilepsy syndrome	1.06e-05	5.26e-05	CcSEcCtD
Donepezil—Headache—Topiramate—epilepsy syndrome	1.05e-05	5.23e-05	CcSEcCtD
Donepezil—Nausea—Topiramate—epilepsy syndrome	9.97e-06	4.96e-05	CcSEcCtD
Donepezil—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.68e-06	0.000134	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.68e-06	0.000134	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC2A1—epilepsy syndrome	8.66e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT3—epilepsy syndrome	8.62e-06	0.000133	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL12—epilepsy syndrome	8.58e-06	0.000132	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	8.58e-06	0.000132	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PLCB1—epilepsy syndrome	8.56e-06	0.000132	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.55e-06	0.000132	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.55e-06	0.000132	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TH—epilepsy syndrome	8.53e-06	0.000132	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	8.48e-06	0.000131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GBE1—epilepsy syndrome	8.48e-06	0.000131	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CNR1—epilepsy syndrome	8.42e-06	0.00013	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.4e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PLCB1—epilepsy syndrome	8.39e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRM1—epilepsy syndrome	8.36e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR7—epilepsy syndrome	8.36e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CHRM1—epilepsy syndrome	8.36e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDYN—epilepsy syndrome	8.36e-06	0.000129	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.29e-06	0.000128	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HTR7—epilepsy syndrome	8.21e-06	0.000127	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—POMC—epilepsy syndrome	8.2e-06	0.000127	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.04e-06	0.000124	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCL2—epilepsy syndrome	8.02e-06	0.000124	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HBEGF—epilepsy syndrome	7.97e-06	0.000123	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.97e-06	0.000123	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.94e-06	0.000123	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.94e-06	0.000123	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.94e-06	0.000123	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.94e-06	0.000123	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CDC42—epilepsy syndrome	7.86e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GAL—epilepsy syndrome	7.86e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GFAP—epilepsy syndrome	7.86e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT3—epilepsy syndrome	7.83e-06	0.000121	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.82e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP2—epilepsy syndrome	7.77e-06	0.00012	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRM5—epilepsy syndrome	7.77e-06	0.00012	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CHRM3—epilepsy syndrome	7.77e-06	0.00012	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.75e-06	0.00012	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.62e-06	0.000118	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.62e-06	0.000118	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AVP—epilepsy syndrome	7.61e-06	0.000118	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.56e-06	0.000117	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.56e-06	0.000117	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CX3CR1—epilepsy syndrome	7.45e-06	0.000115	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.38e-06	0.000114	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.38e-06	0.000114	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.36e-06	0.000114	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CHRM2—epilepsy syndrome	7.31e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BDKRB1—epilepsy syndrome	7.31e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CX3CL1—epilepsy syndrome	7.31e-06	0.000113	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.27e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.27e-06	0.000112	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGF2—epilepsy syndrome	7.25e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	7.21e-06	0.000111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	7.21e-06	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CDC42—epilepsy syndrome	7.14e-06	0.00011	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HMOX1—epilepsy syndrome	7.12e-06	0.00011	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.12e-06	0.00011	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GABBR1—epilepsy syndrome	7.11e-06	0.00011	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	7.06e-06	0.000109	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAT—epilepsy syndrome	7.03e-06	0.000108	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.97e-06	0.000108	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.94e-06	0.000107	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AVP—epilepsy syndrome	6.91e-06	0.000107	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.91e-06	0.000107	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.84e-06	0.000106	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—epilepsy syndrome	6.84e-06	0.000106	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRH3—epilepsy syndrome	6.82e-06	0.000105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.78e-06	0.000105	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RELA—epilepsy syndrome	6.73e-06	0.000104	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.71e-06	0.000104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—OPRM1—epilepsy syndrome	6.71e-06	0.000104	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.65e-06	0.000103	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MTOR—epilepsy syndrome	6.6e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.58e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.58e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.58e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.58e-06	0.000102	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.58e-06	0.000102	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CCR5—epilepsy syndrome	6.47e-06	9.99e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX1—epilepsy syndrome	6.36e-06	9.81e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR3—epilepsy syndrome	6.34e-06	9.78e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.28e-06	9.69e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	6.22e-06	9.61e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NPY—epilepsy syndrome	6.18e-06	9.53e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ATP2A2—epilepsy syndrome	6.18e-06	9.53e-05	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—epilepsy syndrome	6.13e-06	9.46e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.09e-06	9.41e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—epilepsy syndrome	6.07e-06	9.37e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.04e-06	9.33e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.01e-06	9.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.01e-06	9.29e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.01e-06	9.29e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGT—epilepsy syndrome	6.01e-06	9.28e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HSPB1—epilepsy syndrome	5.96e-06	9.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—OXT—epilepsy syndrome	5.96e-06	9.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CRH—epilepsy syndrome	5.96e-06	9.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL3—epilepsy syndrome	5.96e-06	9.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL2—epilepsy syndrome	5.96e-06	9.2e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—JUN—epilepsy syndrome	5.89e-06	9.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCR5—epilepsy syndrome	5.88e-06	9.08e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.8e-06	8.96e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.79e-06	8.94e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—epilepsy syndrome	5.74e-06	8.86e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.59e-06	8.63e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.59e-06	8.63e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AGT—epilepsy syndrome	5.57e-06	8.6e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—epilepsy syndrome	5.56e-06	8.59e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.55e-06	8.57e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTK2B—epilepsy syndrome	5.54e-06	8.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC1—epilepsy syndrome	5.54e-06	8.55e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.51e-06	8.51e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.51e-06	8.51e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.46e-06	8.44e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.46e-06	8.44e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—epilepsy syndrome	5.46e-06	8.43e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGT—epilepsy syndrome	5.46e-06	8.43e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SST—epilepsy syndrome	5.39e-06	8.32e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR2—epilepsy syndrome	5.39e-06	8.32e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK2—epilepsy syndrome	5.39e-06	8.32e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DUSP6—epilepsy syndrome	5.34e-06	8.25e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—epilepsy syndrome	5.29e-06	8.16e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRA2A—epilepsy syndrome	5.27e-06	8.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.26e-06	8.12e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLAT—epilepsy syndrome	5.25e-06	8.11e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—epilepsy syndrome	5.15e-06	7.95e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.11e-06	7.9e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.09e-06	7.86e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL12—epilepsy syndrome	5.07e-06	7.82e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BDKRB2—epilepsy syndrome	5.07e-06	7.82e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—POMC—epilepsy syndrome	5.06e-06	7.81e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PRKCB—epilepsy syndrome	5.04e-06	7.79e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL6ST—epilepsy syndrome	5.02e-06	7.75e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.99e-06	7.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.98e-06	7.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.98e-06	7.7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CNR1—epilepsy syndrome	4.97e-06	7.68e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUNB—epilepsy syndrome	4.97e-06	7.68e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	4.95e-06	7.65e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	4.85e-06	7.49e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.75e-06	7.34e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.75e-06	7.34e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	4.71e-06	7.27e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—POMC—epilepsy syndrome	4.69e-06	7.24e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.65e-06	7.18e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	4.62e-06	7.14e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	4.59e-06	7.09e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.56e-06	7.04e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	4.52e-06	6.97e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	4.49e-06	6.94e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.49e-06	6.94e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.47e-06	6.9e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.45e-06	6.88e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.39e-06	6.77e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.38e-06	6.76e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.35e-06	6.72e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.34e-06	6.7e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.31e-06	6.66e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.28e-06	6.61e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ALB—epilepsy syndrome	4.28e-06	6.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	4.27e-06	6.59e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	4.23e-06	6.53e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	4.22e-06	6.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.1e-06	6.34e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	4.08e-06	6.3e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.98e-06	6.15e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.9e-06	6.03e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.89e-06	6.01e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	3.86e-06	5.96e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	3.75e-06	5.8e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	3.74e-06	5.78e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—epilepsy syndrome	3.74e-06	5.78e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.74e-06	5.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	3.73e-06	5.77e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.72e-06	5.75e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.71e-06	5.72e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.69e-06	5.7e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.61e-06	5.57e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.6e-06	5.56e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.6e-06	5.56e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	3.57e-06	5.51e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	5.48e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.52e-06	5.44e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.51e-06	5.42e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TH—epilepsy syndrome	3.5e-06	5.4e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.48e-06	5.38e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	3.47e-06	5.36e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TH—epilepsy syndrome	3.47e-06	5.36e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.42e-06	5.27e-05	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—epilepsy syndrome	3.29e-06	5.07e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	3.23e-06	4.98e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	3.22e-06	4.98e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	3.16e-06	4.88e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	3.09e-06	4.78e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.98e-06	4.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.97e-06	4.58e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.94e-06	4.54e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	4.51e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.9e-06	4.47e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.88e-06	4.45e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.86e-06	4.42e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.86e-06	4.41e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.84e-06	4.39e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	4.33e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.78e-06	4.29e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	2.71e-06	4.19e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	2.66e-06	4.1e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.61e-06	4.02e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.58e-06	3.99e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.57e-06	3.96e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.44e-06	3.77e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.43e-06	3.76e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	2.4e-06	3.7e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.32e-06	3.59e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.3e-06	3.55e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TH—epilepsy syndrome	2.29e-06	3.53e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.29e-06	3.53e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.27e-06	3.5e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.24e-06	3.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	2.23e-06	3.44e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.22e-06	3.43e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	2.18e-06	3.37e-05	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.03e-06	3.13e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.01e-06	3.1e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.95e-06	3.01e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.92e-06	2.97e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.91e-06	2.95e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.91e-06	2.94e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.9e-06	2.93e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.88e-06	2.91e-05	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—epilepsy syndrome	1.88e-06	2.9e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.84e-06	2.84e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.83e-06	2.83e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.75e-06	2.71e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.75e-06	2.7e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.74e-06	2.68e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.7e-06	2.63e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.7e-06	2.63e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	2.37e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.52e-06	2.35e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.49e-06	2.31e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.46e-06	2.26e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.26e-06	1.94e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.15e-06	1.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.09e-06	1.68e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1e-06	1.55e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.71e-07	1.19e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.65e-07	1.18e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.04e-07	7.79e-06	CbGpPWpGaD
